Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for pain relief after office ureteral stent removal
NCT04112160Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketorolac in pain, sponsored by UT Southwestern Medical Center. Primary endpoint: Number of Participants With Unscheduled Return to Clinic or Emergency Room at 7 days. Started Jun 2018; status: completed.
02
Drugs
ketorolac
03
Conditions
pain
Beyond the preview
Go deeper on NCT04112160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04112160.